Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$80.67 - $352.29 $18,150 - $79,265
225 Added 32.75%
912 $0
Q3 2022

Oct 31, 2022

BUY
$282.54 - $391.85 $125,730 - $174,373
445 Added 183.88%
687 $195,000
Q2 2022

Jul 26, 2022

BUY
$322.67 - $449.65 $78,086 - $108,815
242 New
242 $84,000
Q1 2022

Apr 27, 2022

SELL
$353.85 - $487.79 $470,974 - $649,248
-1,331 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$456.15 - $525.06 $1.52 Million - $1.75 Million
-3,326 Reduced 71.42%
1,331 $689,000
Q3 2021

Nov 03, 2021

BUY
$444.87 - $538.88 $795,872 - $964,056
1,789 Added 62.38%
4,657 $2.26 Million
Q1 2021

Apr 29, 2021

SELL
$314.62 - $411.0 $495,526 - $647,325
-1,575 Reduced 35.45%
2,868 $1.1 Million
Q4 2020

Jan 28, 2021

BUY
$246.9 - $321.87 $280,478 - $365,644
1,136 Added 34.35%
4,443 $1.41 Million
Q3 2020

Oct 29, 2020

SELL
$232.22 - $282.96 $654,395 - $797,381
-2,818 Reduced 46.01%
3,307 $819,000
Q2 2020

Jul 24, 2020

BUY
$185.43 - $279.56 $195,814 - $295,215
1,056 Added 20.83%
6,125 $1.62 Million
Q1 2020

Apr 29, 2020

BUY
$161.17 - $221.51 $29,494 - $40,536
183 Added 3.75%
5,069 $961,000
Q4 2019

Jan 27, 2020

SELL
$189.68 - $222.09 $312,592 - $366,004
-1,648 Reduced 25.22%
4,886 $1.07 Million
Q3 2019

Oct 28, 2019

BUY
$183.56 - $216.72 $308,931 - $364,739
1,683 Added 34.69%
6,534 $1.28 Million
Q2 2019

Jul 30, 2019

BUY
$188.72 - $215.43 $260,999 - $297,939
1,383 Added 39.88%
4,851 $1.01 Million
Q4 2018

Feb 01, 2019

BUY
$132.75 - $203.8 $460,377 - $706,778
3,468 New
3,468 $502,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.96B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.